Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aemetis Inc.

Start price
Target price
Perf. (%)
€8.70
21.02.22
€10.00
21.02.23
-57.00%
22.02.23

Could be very worthwhile Investment >20% year
buy
Marin Software

Start price
Target price
Perf. (%)
€3.54
17.02.22
-
17.02.23
-11.30%
20.02.22

Risky Investment
buy
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€46.21
11.02.22
€96.00
11.02.23
-13.40%
21.02.22

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.70
07.02.22
-
07.02.23
-60.50%
19.09.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€12.78
24.01.22
-
24.01.23
22.85%
07.02.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Energy Focus Inc.

Start price
Target price
Perf. (%)
€15.68
12.01.22
€35.00
12.01.23
-34.38%
24.01.22

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€17.60
10.01.22
-
10.01.23
-27.39%
23.01.22

Risky Investment
buy
Arcadia Biosciences Inc.

Start price
Target price
Perf. (%)
€39.20
08.01.22
€80.00
08.01.23
-18.37%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Marin Software

Start price
Target price
Perf. (%)
€4.30
07.01.22
€6.00
07.01.23
-12.56%
10.01.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€18.94
05.01.22
-
05.01.23
-7.08%
09.01.22

Risky Investment
buy
Neonode Inc.

Start price
Target price
Perf. (%)
€8.40
26.12.21
€6.00
-
28.05.23

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.29
13.12.21
€20.00
13.12.22
-12.88%
30.12.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.80
08.12.21
-
08.12.22
-41.43%
10.12.21

Risky Investment
buy
Applied DNA Sciences Inc.

Start price
Target price
Perf. (%)
€7.40
29.11.21
€14.00
29.11.22
-43.78%
11.12.21

Could be worthwhile Investment >10% per year
Innovative
Capable Management
Few uniques
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.31
27.11.21
-
27.11.22
11.62%
12.12.21

Risky Investment
buy
FuelCell Energy Inc.

Start price
Target price
Perf. (%)
€9.44
09.11.21
€20.00
09.11.22
-68.90%
10.11.22

Could be worthwhile Investment >10% per year
buy
S&P 500

Start price
Target price
Perf. (%)
4,347.3
04.11.21
-
-
29.11.21

buy
Dow Jones

Start price
Target price
Perf. (%)
34,768
04.11.21
-
-
29.11.21

SG Blocks Inc.

Start price
Target price
Perf. (%)
€4.92
25.10.21
-
25.10.22
-35.68%
25.10.21

Risky Investment
SG Blocks Inc.

Start price
Target price
Perf. (%)
€5.07
25.10.21
-
25.10.22
-34.48%
26.10.21

Could be worthwhile Investment >10% per year
Cassava Sciences Inc.

Start price
Target price
Perf. (%)
€39.83
20.10.21
€15.00
31.12.23
-28.06%
28.06.22

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€36.00
18.10.22
31.49%
17.11.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
buy
Regulus Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.44
16.10.21
€8.00
16.10.22
-62.16%
17.10.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€23.62
15.10.21
-
18.01.25
-45.89%
24.01.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies